We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GD icon
501
General Dynamics
GD
$103B
$328K 0.03%
2,810
-3,400
-55% -$387K
DVN icon
502
Devon Energy
DVN
$51.3B
$326K 0.03%
4,100
-3,300
-45% -$240K
SRCL
503
DELISTED
Stericycle Inc
SRCL
$326K 0.03%
+2,752
New +$315K
BCR
504
DELISTED
CR Bard Inc.
BCR
$326K 0.03%
2,280
– –
RTN
505
DELISTED
Raytheon Company
RTN
$325K 0.03%
3,520
-2,600
-42% -$252K
EXPD icon
506
Expeditors International
EXPD
$22.3B
$321K 0.03%
+7,280
New +$313K
PPL
507
PPL Corp
PPL
$26.9B
$320K 0.03%
9,663
-13,309
-58% -$420K
BAP icon
508
Credicorp
BAP
$30.5B
$319K 0.03%
2,050
-454
-18% -$68K
DOC icon
509
Healthpeak Properties
DOC
$15.5B
$317K 0.03%
8,422
-8,784
-51% -$331K
CLC
510
DELISTED
Clarcor
CLC
$317K 0.03%
5,128
– –
TDG icon
511
TransDigm Group
TDG
$70.7B
$316K 0.03%
1,890
+600
+47% +$108K
A icon
512
Agilent Technologies
A
$39.6B
$315K 0.03%
7,675
-3,215
-30% -$129K
DFS
513
DELISTED
Discover Financial Services
DFS
$315K 0.03%
5,080
-4,800
-49% -$280K
NPO icon
514
Enpro
NPO
$6.26B
$315K 0.03%
+4,307
New +$310K
WDAY icon
515
Workday
WDAY
$41.5B
$315K 0.03%
+3,500
New +$275K
CRAY
516
DELISTED
Cray, Inc.
CRAY
$315K 0.03%
11,839
– –
SYNA icon
517
Synaptics
SYNA
$4.05B
$313K 0.03%
3,453
– –
MT icon
518
ArcelorMittal
MT
$49.5B
$308K 0.03%
9,020
+531
+6% +$19.1K
TRMB icon
519
Trimble
TRMB
$13.6B
$307K 0.03%
+8,300
New +$310K
WWD icon
520
Woodward
WWD
$23B
$306K 0.03%
6,101
-800
-12% -$36.4K
WNC icon
521
Wabash National
WNC
$504M
$305K 0.03%
21,372
+2,900
+16% +$39.8K
FCH
522
DELISTED
Felcor Lodging Trust
FCH
$305K 0.03%
29,017
– –
STT icon
523
State Street
STT
$48.4B
$304K 0.03%
4,520
-4,000
-47% -$263K
IFF icon
524
International Flavors & Fragrances
IFF
$20.3B
$302K 0.03%
+2,900
New +$285K
AEP icon
525
American Electric Power
AEP
$70.4B
$301K 0.03%
5,390
-2,700
-33% -$142K
19 20
21
22 23

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.